Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas
dc.contributor.advisor | Govender, Dhiren | en_ZA |
dc.contributor.author | Rademan, Anina | en_ZA |
dc.date.accessioned | 2015-09-15T10:22:33Z | |
dc.date.available | 2015-09-15T10:22:33Z | |
dc.date.issued | 2014 | en_ZA |
dc.description.abstract | Breast cancer management continues to be a challenge due to the heterogeneity of the disease and the fact that individuals with the same stage and pathological diagnosis may respond differently to treatment as a result of differences in gene expression. Several components of the Her-2/PI3K/Akt pathway were evaluated for their relevance as potential prognostic markers or indicators for treatment. A secondary objective was to evaluate the CISH technique for its suitability for analysis of Her-2 gene amplification on archived, Papanicolaou-stained fine needle aspiration (FNA) samples. Tissue blocks from a retrospective series of 93 primary breast carcinoma cases were selected, based on their Her-2 status. Twenty six of these cases received trastuzumab treatment while 67 did not. Expression of Her-2, ER, PI3K, PTEN, p-Akt, BCL2, NFκB, MDM2 and p53 were analysed and compared with various clinicopathological features. The CISH technique was evaluated for its suitability for analysis of Her-2 gene amplification on archived, Papanicolaou-stained FNA samples. | en_ZA |
dc.identifier.apacitation | Rademan, A. (2014). <i>Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas</i>. (Thesis). University of Cape Town ,Faculty of Health Sciences ,Division of Anatomical Pathology. Retrieved from http://hdl.handle.net/11427/13965 | en_ZA |
dc.identifier.chicagocitation | Rademan, Anina. <i>"Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas."</i> Thesis., University of Cape Town ,Faculty of Health Sciences ,Division of Anatomical Pathology, 2014. http://hdl.handle.net/11427/13965 | en_ZA |
dc.identifier.citation | Rademan, A. 2014. Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas. University of Cape Town. | en_ZA |
dc.identifier.ris | TY - Thesis / Dissertation AU - Rademan, Anina AB - Breast cancer management continues to be a challenge due to the heterogeneity of the disease and the fact that individuals with the same stage and pathological diagnosis may respond differently to treatment as a result of differences in gene expression. Several components of the Her-2/PI3K/Akt pathway were evaluated for their relevance as potential prognostic markers or indicators for treatment. A secondary objective was to evaluate the CISH technique for its suitability for analysis of Her-2 gene amplification on archived, Papanicolaou-stained fine needle aspiration (FNA) samples. Tissue blocks from a retrospective series of 93 primary breast carcinoma cases were selected, based on their Her-2 status. Twenty six of these cases received trastuzumab treatment while 67 did not. Expression of Her-2, ER, PI3K, PTEN, p-Akt, BCL2, NFκB, MDM2 and p53 were analysed and compared with various clinicopathological features. The CISH technique was evaluated for its suitability for analysis of Her-2 gene amplification on archived, Papanicolaou-stained FNA samples. DA - 2014 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2014 T1 - Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas TI - Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas UR - http://hdl.handle.net/11427/13965 ER - | en_ZA |
dc.identifier.uri | http://hdl.handle.net/11427/13965 | |
dc.identifier.vancouvercitation | Rademan A. Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas. [Thesis]. University of Cape Town ,Faculty of Health Sciences ,Division of Anatomical Pathology, 2014 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/13965 | en_ZA |
dc.language.iso | eng | en_ZA |
dc.publisher.department | Division of Anatomical Pathology | en_ZA |
dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
dc.publisher.institution | University of Cape Town | |
dc.subject.other | Anatomical Pathology | en_ZA |
dc.title | Evaluation of the P13K pathway and downstream effect in Her-2 positive and negative breast carcinomas | en_ZA |
dc.type | Master Thesis | |
dc.type.qualificationlevel | Masters | |
dc.type.qualificationname | MSc (Med) | en_ZA |
uct.type.filetype | Text | |
uct.type.filetype | Image | |
uct.type.publication | Research | en_ZA |
uct.type.resource | Thesis | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- thesis_hsf_2014_rademan_am.pdf
- Size:
- 4.78 MB
- Format:
- Adobe Portable Document Format
- Description: